Advertisement
Screener

QT IMAGING HOLDINGS, INC. (QTI) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

QT IMAGING HOLDINGS, INC. Net Income (Loss) Available to Common Stockholders, Basic

QT IMAGING HOLDINGS, INC. (QTI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$11.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-12

  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$11.07M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$3.41M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$1.39M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$4.56M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$21.08M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$14.17M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$6.10M.
  • QT IMAGING HOLDINGS, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$3.92M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 2 monthNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 5 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 8 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 11 monthNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2026-06-30-$11.07M
10-Q · filed 2026-08-12
-$14.48M
10-Q · filed 2026-08-12
-$15.86M
derived: sum of 3 quarters · filed 2026-08-12
-$20.42M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$3.41M
10-Q · filed 2026-05-13
-$4.79M
derived: sum of 2 quarters · filed 2026-05-13
-$9.35M
derived: sum of 3 quarters · filed 2026-05-13
-$13.35M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$5.95M
derived: sum of 2 quarters · filed 2026-03-25
-$9.95M
derived: sum of 3 quarters · filed 2026-08-12
-$21.08M
10-K · filed 2026-03-25
2025-09-30-$4.56M
10-Q · filed 2025-11-12
-$8.56M
derived: sum of 2 quarters · filed 2026-08-12
-$19.69M
10-Q · filed 2025-11-12
-$23.18M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$4.00M
10-Q · filed 2026-08-12
-$4.00M
10-Q · filed 2025-08-07
-$15.14M
10-Q · filed 2026-08-12
-$15.14M
10-Q · filed 2025-08-07
-$18.63M
derived: sum of 3 quarters · filed 2026-08-12
-$22.25M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$11.14M
10-Q · filed 2026-05-13
-$14.62M
derived: sum of 2 quarters · filed 2026-05-13
-$18.24M
derived: sum of 3 quarters · filed 2026-05-13
-$24.68M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$3.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$7.11M
derived: sum of 2 quarters · filed 2026-03-25
-$13.54M
derived: sum of 3 quarters · filed 2026-03-25
-$14.17M
10-K · filed 2026-03-25
-$14.17M
10-K · filed 2025-03-31
2024-09-30-$3.62M
10-Q · filed 2025-11-12
-$10.05M
derived: sum of 2 quarters · filed 2025-11-12
-$10.68M
10-Q · filed 2025-11-12
-$14.35M
10-Q · filed 2024-11-13
2024-06-30-$6.43M
10-Q · filed 2025-08-07
-$7.06M
10-Q · filed 2025-08-07
-$10.73M
10-Q · filed 2024-08-08
2023-12-31-$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$2.89M
derived: sum of 2 quarters · filed 2025-03-31
-$4.22M
derived: sum of 3 quarters · filed 2025-03-31
-$6.10M
10-K · filed 2025-03-31
-$5.13M
10-K · filed 2024-03-25
2023-09-30-$1.38M
10-Q · filed 2024-11-13
-$860.77K
10-Q · filed 2023-11-14
-$2.71M
derived: sum of 2 quarters · filed 2024-11-13
-$4.59M
10-Q · filed 2024-11-13
-$4.35M
10-Q · filed 2023-11-14
-$6.13M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$1.33M
10-Q · filed 2024-08-08
-$1.68M
10-Q · filed 2023-08-14
-$3.21M
10-Q · filed 2024-08-08
-$3.49M
10-Q · filed 2023-08-14
-$4.76M
derived: sum of 3 quarters · filed 2024-08-08
-$5.83M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$1.81M
10-Q · filed 2023-05-15
-$3.43M
derived: sum of 2 quarters · filed 2024-03-25
-$4.50M
derived: sum of 3 quarters · filed 2024-03-25
-$5.35M
derived: sum of 4 quarters · filed 2024-03-25
2022-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$2.69M
derived: sum of 2 quarters · filed 2024-03-25
-$3.54M
derived: sum of 3 quarters · filed 2024-03-25
-$3.92M
10-K · filed 2024-03-25
2022-09-30-$1.08M
10-Q · filed 2023-11-14
-$1.92M
derived: sum of 2 quarters · filed 2023-11-14
-$2.30M
10-Q · filed 2023-11-14
2022-06-30-$846.65K
10-Q · filed 2023-08-14
-$1.23M
10-Q · filed 2023-08-14
2022-03-31-$382.33K
10-Q · filed 2023-05-15
2021-12-31-$1.11M
10-K · filed 2023-03-31
2021-09-30-$204.32K
10-Q · filed 2022-11-14
-$240.07K
10-Q · filed 2022-11-14
2021-06-30-$35.75K
10-Q · filed 2022-08-15
2021-03-31-$35.75K
10-Q · filed 2022-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Nuwellis, Inc. (NUWE)United States$0.003B
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B